You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb511272 |
---|---|
Category | Proteins |
Description | Human CD30 Ligand Protein, Mouse IgG2a Fc Tag is expressed from human 293 cells (HEK293). It contains AA Gln 63 - Asp 234 (Accession # P32971-1). |
Reactivity | Human |
Tag | N-mFc(mIgG2a) |
Form/Appearance | Powder |
Purity | 95% |
Conjugation | Unconjugated |
MW | 46.5 kDa |
Target | CD30 ligand |
UniProt ID | P32971 |
Protein Sequence | NP_001235.1 |
Source | Human CD30 Ligand Protein, Mouse IgG2a Fc Tag (orb511272) is expressed from human 293 cells (HEK293). It contains AA Gln 63 - Asp 234 (Accession # P32971-1). |
Expression System | HEK293 |
Biological Origin | Human |
Expression Region | Gln 63 - Asp 234 |
Endotoxins | 0.1 EU per μg |
NCBI | NP_001235.1 |
Storage | -20℃ |
Buffer/Preservatives | Tris with Glycine, Arginine and NaCl, pH7.5 |
Alternative names | CD30-L,CD153,TNFSF8,CD30L,CD30LG,CD153 antigen,CD3 Read more... |
Note | For research use only |
Application notes | This protein carries a mouse IgG2a Fc tag at the N-terminus. The protein has a calculated MW of 46.5 kDa. The protein migrates as 55-65 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation. |
Expiration Date | 6 months from date of receipt. |
> 95% by SDS-PAGE. | |
Recombinant Human IL-13 R alpha 1 Protein is produced by mammalian expression system. The target protein is expressed with sequence (Gln63-Asp234) of human CD30 Ligand/TNFSF8 (Accession #P32971-1) fused with an Fc at the N-terminus. |
> 95% by SDS-PAGE. | |
Recombinant Human IL-13 R alpha 1 Protein is produced by mammalian expression system. The target protein is expressed with sequence (Gln63-Asp234) of human CD30 Ligand/TNFSF8 (Accession #P32971-1) fused with an Fc at the N-terminus. |
Unconjugated | |
90% | |
21.5 kDa | |
Human CD30 Ligand Protein, His Tag (orb570264) is expressed from human 293 cells (HEK293). It contains AA Gln 63 - Asp 234 (Accession # P32971-1). |